The reduction removes redundant pair inequalities while preserving the induced order cone, providing an exact compression of the deployed pair system used in CG
Doses typically start at 2 mg and increase gradually to 4, 8, or 12 mg over several weeks to help reduce the severity of side effects
Getting started at Meeting Point Health is simple
Peptide therapy is not recommended for individuals who are: -Pregnant or breastfeeding -Diagnosed with active cancer or hormone-sensitive tumors or high risk -Undergoing immunosuppressive therapy (unless cleared by their specialist) -Experiencing uncontrolled endocrine disorders Always consult your provider and disclose your full medical history before starting any peptide protocol
Classically, with ipamorelin, hexarelin, GHRP-6, we would add this other compound, CJC-1295, which is going to work on the GHRH, which allows the peptide and then the growth hormone to stay in your system a little bit longer